Data from Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder Cancer Article Swipe

View

Rou Wang , David S. Morris , Scott A. Tomlins , Robert J. Lonigro , Alexander Tsodikov , Rohit Mehra , Thomas J. Giordano , L. Priya Kunju , Cheryl T. Lee , Alon Z. Weizer , Arul M. Chinnaiyan ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/0008-5472.c.6499742.v1

In bladder cancer, clinical grade and stage fail to capture outcome. We developed a clinically applicable quantitative PCR (QPCR) gene signature to predict progression in non–muscle-invasive bladder cancer. Comparative metaprofiling of 12 DNA microarray data sets (comprising 631 samples and 241,298 probe sets) identified 96 genes, which showed differential expression in seven clinical outcome categories, or were identified as outliers, historic markers, or housekeeping genes. QPCR was done to determine mRNA expression from 96 bladder tumors. Fifty-seven genes differentiated T2 from non-T2 tumors (P < 0.05). Principal components analysis and Cox regression models were used to predict probability of T2 progression for non-T2 patients, placing them into high- and low-risk groups based on their gene expression. At 2 years, high-risk patients exhibited greater T2 progression (45% for high-risk patients versus 12% for low-risk patients; P = 0.003, log-rank test). This difference remained significant within T1 tumors (61% for high-risk patients versus 22% for low-risk patients; P = 0.02) and Ta tumors (29% for high-risk patients versus 0% for low-risk patients; P = 0.03). The best multivariate Cox model included stage and gender, and this signature provided predictive improvement over both (P = 0.002, likelihood ratio test). Immunohistochemistry was done for two genes in the signature not previously described in bladder cancer, ACTN1 and CDC25B, corroborating their up-regulation at the protein level with disease progression. Thus, we identified a 57-gene QPCR panel to help predict progression of non–muscle-invasive bladder cancers and delineate a systematic, generalizable approach to converting microarray data into a multiplex assay for cancer progression. [Cancer Res 2009;69(9):3810–8]

Related Topics

Polymerase Chain Reaction

Concepts

Bladder cancer Proportional hazards model Internal medicine Gene signature Oncology Medicine Multiplex polymerase chain reaction Cancer Gene expression Biology Gene Polymerase chain reaction Genetics

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/0008-5472.c.6499742.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361239019

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361239019

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/0008-5472.c.6499742.v1

Digital Object Identifier
Title: Data from Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder Cancer

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-30

Full publication date if available
Authors: Rou Wang, David S. Morris, Scott A. Tomlins, Robert J. Lonigro, Alexander Tsodikov, Rohit Mehra, Thomas J. Giordano, L. Priya Kunju, Cheryl T. Lee, Alon Z. Weizer, Arul M. Chinnaiyan

List of authors in order
Landing page: https://doi.org/10.1158/0008-5472.c.6499742.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/0008-5472.c.6499742.v1

Direct OA link when available
Concepts: Bladder cancer, Proportional hazards model, Internal medicine, Gene signature, Oncology, Medicine, Multiplex polymerase chain reaction, Cancer, Gene expression, Biology, Gene, Polymerase chain reaction, Genetics

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361239019
doi	https://doi.org/10.1158/0008-5472.c.6499742.v1
ids.doi	https://doi.org/10.1158/0008-5472.c.6499742.v1
ids.openalex	https://openalex.org/W4361239019
fwci
type	preprint
title	Data from Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder Cancer
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10458
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9990000128746033
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2746
topics[0].subfield.display_name	Surgery
topics[0].display_name	Bladder and Urothelial Cancer Treatments
topics[1].id	https://openalex.org/T12695
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9599000215530396
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2746
topics[1].subfield.display_name	Surgery
topics[1].display_name	Urinary and Genital Oncology Studies
topics[2].id	https://openalex.org/T11970
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.9419000148773193
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1312
topics[2].subfield.display_name	Molecular Biology
topics[2].display_name	Molecular Biology Techniques and Applications
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2780352672
concepts[0].level	3
concepts[0].score	0.7983860969543457
concepts[0].wikidata	https://www.wikidata.org/wiki/Q504775
concepts[0].display_name	Bladder cancer
concepts[1].id	https://openalex.org/C50382708
concepts[1].level	2
concepts[1].score	0.5802307724952698
concepts[1].wikidata	https://www.wikidata.org/wiki/Q223218
concepts[1].display_name	Proportional hazards model
concepts[2].id	https://openalex.org/C126322002
concepts[2].level	1
concepts[2].score	0.5662471652030945
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[2].display_name	Internal medicine
concepts[3].id	https://openalex.org/C2779733811
concepts[3].level	4
concepts[3].score	0.5115781426429749
concepts[3].wikidata	https://www.wikidata.org/wiki/Q5531562
concepts[3].display_name	Gene signature
concepts[4].id	https://openalex.org/C143998085
concepts[4].level	1
concepts[4].score	0.48768365383148193
concepts[4].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[4].display_name	Oncology
concepts[5].id	https://openalex.org/C71924100
concepts[5].level	0
concepts[5].score	0.48168620467185974
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[5].display_name	Medicine
concepts[6].id	https://openalex.org/C90583042
concepts[6].level	4
concepts[6].score	0.4473513662815094
concepts[6].wikidata	https://www.wikidata.org/wiki/Q1952456
concepts[6].display_name	Multiplex polymerase chain reaction
concepts[7].id	https://openalex.org/C121608353
concepts[7].level	2
concepts[7].score	0.42450425028800964
concepts[7].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[7].display_name	Cancer
concepts[8].id	https://openalex.org/C150194340
concepts[8].level	3
concepts[8].score	0.4044346511363983
concepts[8].wikidata	https://www.wikidata.org/wiki/Q26972
concepts[8].display_name	Gene expression
concepts[9].id	https://openalex.org/C86803240
concepts[9].level	0
concepts[9].score	0.34320157766342163
concepts[9].wikidata	https://www.wikidata.org/wiki/Q420
concepts[9].display_name	Biology
concepts[10].id	https://openalex.org/C104317684
concepts[10].level	2
concepts[10].score	0.34090399742126465
concepts[10].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[10].display_name	Gene
concepts[11].id	https://openalex.org/C49105822
concepts[11].level	3
concepts[11].score	0.22278055548667908
concepts[11].wikidata	https://www.wikidata.org/wiki/Q176996
concepts[11].display_name	Polymerase chain reaction
concepts[12].id	https://openalex.org/C54355233
concepts[12].level	1
concepts[12].score	0.07957413792610168
concepts[12].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[12].display_name	Genetics
keywords[0].id	https://openalex.org/keywords/bladder-cancer
keywords[0].score	0.7983860969543457
keywords[0].display_name	Bladder cancer
keywords[1].id	https://openalex.org/keywords/proportional-hazards-model
keywords[1].score	0.5802307724952698
keywords[1].display_name	Proportional hazards model
keywords[2].id	https://openalex.org/keywords/internal-medicine
keywords[2].score	0.5662471652030945
keywords[2].display_name	Internal medicine
keywords[3].id	https://openalex.org/keywords/gene-signature
keywords[3].score	0.5115781426429749
keywords[3].display_name	Gene signature
keywords[4].id	https://openalex.org/keywords/oncology
keywords[4].score	0.48768365383148193
keywords[4].display_name	Oncology
keywords[5].id	https://openalex.org/keywords/medicine
keywords[5].score	0.48168620467185974
keywords[5].display_name	Medicine
keywords[6].id	https://openalex.org/keywords/multiplex-polymerase-chain-reaction
keywords[6].score	0.4473513662815094
keywords[6].display_name	Multiplex polymerase chain reaction
keywords[7].id	https://openalex.org/keywords/cancer
keywords[7].score	0.42450425028800964
keywords[7].display_name	Cancer
keywords[8].id	https://openalex.org/keywords/gene-expression
keywords[8].score	0.4044346511363983
keywords[8].display_name	Gene expression
keywords[9].id	https://openalex.org/keywords/biology
keywords[9].score	0.34320157766342163
keywords[9].display_name	Biology
keywords[10].id	https://openalex.org/keywords/gene
keywords[10].score	0.34090399742126465
keywords[10].display_name	Gene
keywords[11].id	https://openalex.org/keywords/polymerase-chain-reaction
keywords[11].score	0.22278055548667908
keywords[11].display_name	Polymerase chain reaction
keywords[12].id	https://openalex.org/keywords/genetics
keywords[12].score	0.07957413792610168
keywords[12].display_name	Genetics
language	en
locations[0].id	doi:10.1158/0008-5472.c.6499742.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/0008-5472.c.6499742.v1
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5087775770
authorships[0].author.orcid
authorships[0].author.display_name	Rou Wang
authorships[0].author_position	first
authorships[0].raw_author_name	Rou Wang
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5086266079
authorships[1].author.orcid	https://orcid.org/0000-0001-7036-2849
authorships[1].author.display_name	David S. Morris
authorships[1].author_position	middle
authorships[1].raw_author_name	David S. Morris
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5068238406
authorships[2].author.orcid	https://orcid.org/0000-0001-8661-9821
authorships[2].author.display_name	Scott A. Tomlins
authorships[2].author_position	middle
authorships[2].raw_author_name	Scott A. Tomlins
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5112085174
authorships[3].author.orcid
authorships[3].author.display_name	Robert J. Lonigro
authorships[3].author_position	middle
authorships[3].raw_author_name	Robert J. Lonigro
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5008923373
authorships[4].author.orcid	https://orcid.org/0000-0003-4507-2879
authorships[4].author.display_name	Alexander Tsodikov
authorships[4].author_position	middle
authorships[4].raw_author_name	Alexander Tsodikov
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5060849370
authorships[5].author.orcid	https://orcid.org/0000-0002-6955-8884
authorships[5].author.display_name	Rohit Mehra
authorships[5].author_position	middle
authorships[5].raw_author_name	Rohit Mehra
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5077701232
authorships[6].author.orcid	https://orcid.org/0000-0003-0641-8873
authorships[6].author.display_name	Thomas J. Giordano
authorships[6].author_position	middle
authorships[6].raw_author_name	Thomas J. Giordano
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5045593407
authorships[7].author.orcid
authorships[7].author.display_name	L. Priya Kunju
authorships[7].author_position	middle
authorships[7].raw_author_name	L. Priya Kunju
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5032617990
authorships[8].author.orcid
authorships[8].author.display_name	Cheryl T. Lee
authorships[8].author_position	middle
authorships[8].raw_author_name	Cheryl T. Lee
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5018208869
authorships[9].author.orcid	https://orcid.org/0000-0002-0504-2969
authorships[9].author.display_name	Alon Z. Weizer
authorships[9].author_position	middle
authorships[9].raw_author_name	Alon Z. Weizer
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5003311852
authorships[10].author.orcid	https://orcid.org/0000-0001-9282-3415
authorships[10].author.display_name	Arul M. Chinnaiyan
authorships[10].author_position	last
authorships[10].raw_author_name	Arul M. Chinnaiyan
authorships[10].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/0008-5472.c.6499742.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Data from Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder Cancer
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10458
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9990000128746033
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2746
primary_topic.subfield.display_name	Surgery
primary_topic.display_name	Bladder and Urothelial Cancer Treatments
related_works	https://openalex.org/W2898558914, https://openalex.org/W4237262135, https://openalex.org/W3127976301, https://openalex.org/W2981899172, https://openalex.org/W1522132782, https://openalex.org/W2160411124, https://openalex.org/W2944005863, https://openalex.org/W2943930186, https://openalex.org/W2952297142, https://openalex.org/W3197036096
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/0008-5472.c.6499742.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/0008-5472.c.6499742.v1
primary_location.id	doi:10.1158/0008-5472.c.6499742.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/0008-5472.c.6499742.v1
publication_date	2023-03-30
publication_year	2023
referenced_works_count	0
abstract_inverted_index.2	117
abstract_inverted_index.=	135, 156, 171, 191
abstract_inverted_index.a	13, 227, 241, 250
abstract_inverted_index.0%	166
abstract_inverted_index.12	31
abstract_inverted_index.96	44, 73
abstract_inverted_index.At	116
abstract_inverted_index.T1	144
abstract_inverted_index.T2	79, 99, 123
abstract_inverted_index.Ta	159
abstract_inverted_index.We	11
abstract_inverted_index.as	58
abstract_inverted_index.at	217
abstract_inverted_index.in	24, 50, 202, 208
abstract_inverted_index.of	30, 98, 235
abstract_inverted_index.on	112
abstract_inverted_index.or	55, 62
abstract_inverted_index.to	8, 21, 68, 95, 231, 245
abstract_inverted_index.we	225
abstract_inverted_index.12%	130
abstract_inverted_index.22%	151
abstract_inverted_index.631	37
abstract_inverted_index.Cox	90, 176
abstract_inverted_index.DNA	32
abstract_inverted_index.PCR	17
abstract_inverted_index.Res	257
abstract_inverted_index.The	173
abstract_inverted_index.and	5, 39, 89, 108, 158, 180, 182, 212, 239
abstract_inverted_index.for	101, 126, 131, 147, 152, 162, 167, 199, 253
abstract_inverted_index.not	205
abstract_inverted_index.the	203, 218
abstract_inverted_index.two	200
abstract_inverted_index.was	66, 197
abstract_inverted_index.<	84
abstract_inverted_index.(29%	161
abstract_inverted_index.(45%	125
abstract_inverted_index.(61%	146
abstract_inverted_index.QPCR	65, 229
abstract_inverted_index.This	139
abstract_inverted_index.best	174
abstract_inverted_index.both	189
abstract_inverted_index.data	34, 248
abstract_inverted_index.done	67, 198
abstract_inverted_index.fail	7
abstract_inverted_index.from	72, 80
abstract_inverted_index.gene	19, 114
abstract_inverted_index.help	232
abstract_inverted_index.into	106, 249
abstract_inverted_index.mRNA	70
abstract_inverted_index.over	188
abstract_inverted_index.sets	35
abstract_inverted_index.them	105
abstract_inverted_index.this	183
abstract_inverted_index.used	94
abstract_inverted_index.were	56, 93
abstract_inverted_index.with	221
abstract_inverted_index.0.02)	157
abstract_inverted_index.Thus,	224
abstract_inverted_index.assay	252
abstract_inverted_index.based	111
abstract_inverted_index.genes	77, 201
abstract_inverted_index.grade	4
abstract_inverted_index.high-	107
abstract_inverted_index.level	220
abstract_inverted_index.model	177
abstract_inverted_index.panel	230
abstract_inverted_index.probe	41
abstract_inverted_index.ratio	194
abstract_inverted_index.sets)	42
abstract_inverted_index.seven	51
abstract_inverted_index.stage	6, 179
abstract_inverted_index.their	113, 215
abstract_inverted_index.which	46
abstract_inverted_index.(QPCR)	18
abstract_inverted_index.0.002,	192
abstract_inverted_index.0.003,	136
abstract_inverted_index.0.03).	172
abstract_inverted_index.0.05).	85
abstract_inverted_index.cancer	254
abstract_inverted_index.genes,	45
abstract_inverted_index.genes.	64
abstract_inverted_index.groups	110
abstract_inverted_index.models	92
abstract_inverted_index.non-T2	81, 102
abstract_inverted_index.showed	47
abstract_inverted_index.test).	138, 195
abstract_inverted_index.tumors	82, 145, 160
abstract_inverted_index.versus	129, 150, 165
abstract_inverted_index.within	143
abstract_inverted_index.years,	118
abstract_inverted_index.241,298	40
abstract_inverted_index.57-gene	228
abstract_inverted_index.[Cancer	256
abstract_inverted_index.bladder	1, 26, 74, 209, 237
abstract_inverted_index.cancer,	2, 210
abstract_inverted_index.cancer.	27
abstract_inverted_index.cancers	238
abstract_inverted_index.capture	9
abstract_inverted_index.disease	222
abstract_inverted_index.gender,	181
abstract_inverted_index.greater	122
abstract_inverted_index.outcome	53
abstract_inverted_index.placing	104
abstract_inverted_index.predict	22, 96, 233
abstract_inverted_index.protein	219
abstract_inverted_index.samples	38
abstract_inverted_index.tumors.	75
abstract_inverted_index.analysis	88
abstract_inverted_index.approach	244
abstract_inverted_index.clinical	3, 52
abstract_inverted_index.historic	60
abstract_inverted_index.included	178
abstract_inverted_index.log-rank	137
abstract_inverted_index.low-risk	109, 132, 153, 168
abstract_inverted_index.markers,	61
abstract_inverted_index.outcome.	10
abstract_inverted_index.patients	120, 128, 149, 164
abstract_inverted_index.provided	185
abstract_inverted_index.remained	141
abstract_inverted_index.Principal	86
abstract_inverted_index.delineate	240
abstract_inverted_index.described	207
abstract_inverted_index.determine	69
abstract_inverted_index.developed	12
abstract_inverted_index.exhibited	121
abstract_inverted_index.high-risk	119, 127, 148, 163
abstract_inverted_index.multiplex	251
abstract_inverted_index.outliers,	59
abstract_inverted_index.patients,	103
abstract_inverted_index.patients;	133, 154, 169
abstract_inverted_index.signature	20, 184, 204
abstract_inverted_index.applicable	15
abstract_inverted_index.clinically	14
abstract_inverted_index.components	87
abstract_inverted_index.converting	246
abstract_inverted_index.difference	140
abstract_inverted_index.expression	49, 71
abstract_inverted_index.identified	43, 57, 226
abstract_inverted_index.likelihood	193
abstract_inverted_index.microarray	33, 247
abstract_inverted_index.predictive	186
abstract_inverted_index.previously	206
abstract_inverted_index.regression	91
abstract_inverted_index.(comprising	36
abstract_inverted_index.Comparative	28
abstract_inverted_index.Fifty-seven	76
abstract_inverted_index.categories,	54
abstract_inverted_index.expression.	115
abstract_inverted_index.improvement	187
abstract_inverted_index.probability	97
abstract_inverted_index.progression	23, 100, 124, 234
abstract_inverted_index.significant	142
abstract_inverted_index.systematic,	242
abstract_inverted_index.differential	48
abstract_inverted_index.housekeeping	63
abstract_inverted_index.multivariate	175
abstract_inverted_index.progression.	223, 255
abstract_inverted_index.quantitative	16
abstract_inverted_index.corroborating	214
abstract_inverted_index.generalizable	243
abstract_inverted_index.metaprofiling	29
abstract_inverted_index.up-regulation	216
abstract_inverted_index.differentiated	78
abstract_inverted_index.<i>P</i>	134, 155, 170
abstract_inverted_index.Immunohistochemistry	196
abstract_inverted_index.(<i>P</i>	83, 190
abstract_inverted_index.non–muscle-invasive	25, 236
abstract_inverted_index.<i>ACTN1</i>	211
abstract_inverted_index.<i>CDC25B</i>,	213
abstract_inverted_index.<div>Abstract<p>In	0
abstract_inverted_index.2009;69(9):3810–8]</p></div>	258
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	11
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5099999904632568
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.07081999
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False